Inactive

This notice is for planning purposes only and does not constitute a commitment on the part of the Government to award a contract, nor does the Government intend to pay for any information submitted as... This notice is for planning purposes only and does not constitute a commitment on the part of the Government to award a contract, nor does the Government intend to pay for any information submitted as a result of this notice. This Sources Sought is part of a continuous process for obtaining the latest information on the commercial status of the industry with respect to their current and near-term abilities. The information provided herein is subject to change and in no way binds the Government to solicit for, or award, a competitive contract. It is emphasized that this is a notice solely for planning and informational purposes. The Veterans Health Administration (VHA) Non-Expendable Equipment (NX) National Program has identified the Negative Pressure Wound Therapy Systems product line as a candidate for inclusion in the National Equipment Catalog (NEC). This will be accomplished via the awarding of multiple Blanket Purchase Agreements (BPAs). Negative Pressure Wound Therapy Systems are designed to treat open wounds by locally applying negative pressure to the wound site. These systems consist of dressings, an evacuation tube, a collection canister, and a computer-controlled vacuum pump. The dressings usually include a foam (e.g., black polyurethane, polyvinyl alcohol) dressing with an evacuation tube embedded in it and a transparent film dressing that is applied over the foam package to seal the foam and the tube. The other end of the tube is connected to a fluid-collection canister, which, in turn, is attached to the vacuum pump. The computer-controlled vacuum pump applies either continuous or intermittent negative pressure through the tube to the foam dressing, drawing off excess of interstitial fluids from the wound. Negative Pressure Wound Therapy Systems decompress the capillaries and lymphatic vessels, thus improving blood flow to the wound and reestablishing normal circulation of interstitial fluids. They are intended to promote healing of wounds (e.g., chronic wounds, burns) that are difficult to heal using conventional treatments. The Contractor must demonstrate the ability to meet all requirements for the solicitation. The objective is to provide Negative Pressure Wound Therapy Systems to be used by clinicians throughout the VA medical centers and facilities. The period of performance is for a 60-month ordering period. The objective of this procurement is to establish BPAs for Negative Pressure Wound Therapy Systems for inclusion in the NEC and nationwide usage. VHA aims to ensure availability and consistency of NX equipment and to obtain volume-based, standardized pricing. VHA desires to continue the practice of achieving cost avoidance while simultaneously balancing clinician considerations for obtaining quality equipment. For each product, the offeror must include a description reflecting the minimum technical requirements (MTRs) and level of quality that will satisfy the physical, functional, or performance characteristics of the product(s) specified in the solicitation. The offeror must also clearly identify the item by brand name (if any) and make/model number. Finally, the offeror must include descriptive literature, such as illustrations, drawings, or a clear reference to previously furnished descriptive data or information available to the Contracting Officer, and clearly describe any modifications it plans to make to a product to make it conform to the solicitation requirements. The following line items comprise the Negative Pressure Wound Therapy Systems product line: Table 1. Contract Line Items Contract Line Items Description 0001 Negative Pressure Wound Therapy Systems The Department of Veterans Affairs (VA) is seeking vendors who can provide Negative Pressure Wound Therapy Systems identified above which meet all the following minimum technical requirements (MTRs). The Government's intent is for offerors to include all ancillary items to ensure the equipment can function as designed by the OEM and as clinically required. Vendors are encouraged to provide any product solution or configuration so long as they meet the minimum technical requirements. Additionally, responses can include any additional product and other product-related services necessary to obtain the supplies as required that may be beneficial and essential to the functionality of the proposed solution. These items must be clearly identified by brand name, brand name or equal, and part number. When offerors include their additional proposed product items/services, these items may be considered for evaluation, and must be captured in the vendor s pricing volume with an estimated quantity of zero CLIN 0001 applies to the following MTR s in Table 2. Table 2. Minimum Technical Requirements MTR # Minimum Technical Requirements Method Of Evaluation MTR Met by OEMs in use (table below) MTR 1 The NPWT system deliveries negative pressure to provide wound exudate management for the treatment of acute and chronic wounds, both continuous and intermittent therapy modes. Literature Review ECRI Market Intelligence Report MTR 2 Must have at a minimum be equipped with a 300ml canister. Literature Review ECRI Market Intelligence Report MTR 3 NPWTS must include a battery with capacity to provide full operation for a minimum of 6 hours. Literature Review ECRI Market Intelligence Report MTR 4 Pressure setting must range from minimum -40mmhg to -200mmhg. Literature Review ECRI Market Intelligence Report MTR 5 Must be designed for hospital inpatient use for acute and post-acute care. Literature Review ECRI Market Intelligence Report For each product (brand name and part number), the response must include descriptive literature demonstrating the product meets or exceeds the salient characteristics (SC) specified above. The Government's intent is to include all ancillary items to ensure the equipment can function as designed by the OEM and as clinically required. Vendors are encouraged to provide any product solution or configuration so long as they meet the salient characteristics. Additionally, responses can include any additional product that may be beneficial. These items must be clearly identified by brand name and part number. Responses to this Sources Sought Notice shall include the following: Full name and address of company Unique Entity ID Number Business Size Manufacturer or Distributor If distributor provide full name, business size and address of manufacturer Country of Origin designation for all products Ability to provide uninterrupted supply of products on a national scale Technical Literature that clearly shows product(s) meet the identified salient characteristics (if submitting an or-equal item) Any additional product solution or configuration that would be beneficial to the clinical functionality of the product line identified Although not required, vendors responding to this Sources Sought may also submit a Capabilities Statement. CONTACT INFORMATION AND RESPONSE DUE DATE: Please email all responses to kever.swafford@va.gov. Please respond to this SS no later than April 25, 2023 @08:30 AM CST DISCLAIMER: This Sources Sought Notice is issued solely for informational and planning purposes and does not constitute a solicitation. Responses to this notice are not offers and cannot be accepted by the Department of Veterans Affairs to form a binding contract. Respondents are solely responsible for all expenses associated with responding to this Sources Sought Notice.